Prior studies have shown that mutations in the TOP2A gene have a significant effect on the outlook for individuals with ovarian cancer (59), with increased levels of TOP2A protein expression observed in ovarian cancer tissues (55). The gene discussed is TOP2A; the disease is ovarian carcinoma.